Kirwan J P, Huston-Presley L, Kalhan S C, Catalano P M
Department of Reproductive Biology, Case Western Reserve University School of Medicine at MetroHealth Medical Center, Bell Greve Building, 2500 MetroHealth Dr., Cleveland, OH 44109-1998, USA.
Diabetes Care. 2001 Sep;24(9):1602-7. doi: 10.2337/diacare.24.9.1602.
We examined whether selected indexes of insulin sensitivity derived from an oral glucose tolerance test (IS(OGTT)) or fasting glucose/insulin levels (IS(QUICKI) and IS(HOMA)) can be used to predict insulin sensitivity in women before and during pregnancy.
A 2-h euglycemic-hyperinsulinemic clamp (5 mmol/l glucose, 40 mU. m(-2). min(-1) insulin) and a 120-min oral glucose tolerance test (75 g load pregravid, 100 g pregnant) were repeated on 15 women (10 with normal glucose tolerance [NGT] and 5 with gestational diabetes mellitus [GDM]) pregravid and during both early (12-14 weeks) and late (34-36 weeks) pregnancy. An index of insulin sensitivity derived from the clamp (IS(CLAMP)) was obtained from glucose infusion rates adjusted for change in fat-free mass and endogenous glucose production measured using [6,6(-2)H(2)]glucose.
Univariate analysis using combined groups and periods of pregnancy resulted in significant correlations between IS(CLAMP) and IS(OGTT) (r(2) = 0.74, P < 0.0001), IS(QUICKI) (r(2) = 0.64, P < 0.0001), and IS(HOMA) (r(2) = 0.53, P < 0.0001). The IS(OGTT) provided a significantly better correlation (P < 0.0001) than either IS(QUICKI) or IS(HOMA.) Multivariate analysis showed a significant group effect (P < 0.0003) on the prediction model, and separate equations were developed for the NGT (r(2) = 0.64, P < 0.0001) and GDM (r(2) = 0.85, P < 0.0001) groups. When subdivided by period of pregnancy, the correlation between IS(CLAMP) and IS(OGTT) pregravid was r(2) = 0.63 (P = 0.0002), during early pregnancy was r(2) = 0.80 (P < 0.0001), and during late pregnancy was r(2) = 0.64 (P = 0.0002).
Estimates of insulin sensitivity from the IS(OGTT) during pregnancy were significantly better than from fasting glucose and insulin values. However, separate prediction equations are necessary for pregnant women with NGT and women with GDM.
我们研究了源自口服葡萄糖耐量试验(IS(OGTT))或空腹血糖/胰岛素水平(IS(QUICKI)和IS(HOMA))的胰岛素敏感性选定指标是否可用于预测女性孕前及孕期的胰岛素敏感性。
对15名女性(10名糖耐量正常[NGT],5名患有妊娠期糖尿病[GDM])在孕前、孕早期(12 - 14周)和孕晚期(34 - 36周)重复进行2小时正常血糖高胰岛素钳夹试验(5 mmol/l葡萄糖,40 mU·m⁻²·min⁻¹胰岛素)和120分钟口服葡萄糖耐量试验(孕前75 g负荷,孕期100 g负荷)。从钳夹试验获得的胰岛素敏感性指标(IS(CLAMP))通过根据无脂肪体重变化和使用[6,6(-2)H₂]葡萄糖测量的内源性葡萄糖生成进行调整的葡萄糖输注率得出。
对合并的孕期组进行单因素分析,结果显示IS(CLAMP)与IS(OGTT)(r² = 0.74,P < 0.0001)、IS(QUICKI)(r² = 0.64,P < 0.0001)和IS(HOMA)(r² = 0.53,P < 0.0001)之间存在显著相关性。IS(OGTT)的相关性显著优于IS(QUICKI)或IS(HOMA)(P < 0.0001)。多因素分析显示预测模型存在显著的组效应(P < 0.0003),并为NGT组(r² = 0.64,P < 0.0001)和GDM组(r² = 0.85,P < 0.0001)分别建立了方程。按孕期细分时,孕前IS(CLAMP)与IS(OGTT)的相关性为r² = 0.63(P = 0.0002),孕早期为r² = 0.80(P < 0.0001),孕晚期为r² = 0.64(P = 0.0002)。
孕期通过IS(OGTT)评估的胰岛素敏感性明显优于通过空腹血糖和胰岛素值评估的结果。然而,对于NGT孕妇和GDM孕妇需要分别建立预测方程。